Evidence map›Paper›PMID 16821708›Full record

ArticleFolia microbiologica2006

Modulation of complement activity in vitro and in vivo by Yersinia wild and mutant strains.

M Yordanov, E Golkocheva, H Najdenski

Abstract read
PubMed Publisher
In one paragraph

Article in Folia microbiologica, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M YordanovDepartment of Immunology, Institute of Microbiology, Sofia, Bulgaria. martin@microbio.bas.bg
E Golkocheva
H Najdenski
Institute of Mechanics · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability of released proteins (Yops) and surface lipopolysaccharides (LPS) from the wild-type strain Yersinia enterocolitica 8081-L2, serotype 0:8 to influence the complement activity was determined. Yops and LPS from wild-type and mutant strains showed different ability to affect the classical pathway (CP) functional complement activity in vitro. The serum CP activity was inhibited during the infection induced with six Y. enterocolitica and three Y. pseudotuberculosis strains in rabbits. The changed complement activity might be of importance for the course of Yersinia infections.

Indexed as

AnimalsBacterial Outer Membrane ProteinsComplement Hemolytic Activity AssayComplement Inactivating AgentsComplement Pathway, ClassicalDisease Models, AnimalLipopolysaccharidesRabbitsYersinia enterocoliticaYersinia InfectionsYersinia pseudotuberculosisYersinia pseudotuberculosis InfectionsBacterial Outer Membrane ProteinsComplement Inactivating AgentsLipopolysaccharides

Identifiers

PMID16821708
OpenAlexW2182760178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.